Skip to content
Oral Suspension Allopathic

Pepto-Care 87.5 mg/5 ml oral suspension

Generic: Bismuth Subsalicylate

Company: UniMed UniHealth Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength87.5 mg/5 ml
PackOne bottle

Reviewed by: not listed yet. Source: not listed yet.

Last updated April 9, 2025.

Compare

Same generic, same strength

Sorted by price per oral suspension. Ask your pharmacist before you switch brands.

Bismuth Subsalicylate 87.5 mg/5 ml oral suspensions

Prices as listed on BestinMeds.

2 brands listed
Peptocid, 200.00 ml0.48 taka per oral suspension
Pepto-Care, 200.00 ml (this medicine)0.75 taka per oral suspension

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Bismuth Subsalicylate guide

Indications

  Bismuth Subsalicylate is indicated for- upset stomach indigestion heartburn nausea and diarrhea.

Dosage and administration

Adult (>16): 30 ml in dosing cup provided or 6x5 ml spoonful Children (10-14 years): 15 mL (3 teaspoons) Children (5-9 years): 7.5 mL (1.5 teaspoons) Children (3-4 years): 5 mL (1 teaspoon) Children under 3 years: Ask a doctor. Use in the elderly: No special precaution is needed. Patient is suffering from renal insufficiency: caution should be taken. Repeat dose every ½ to 1 hour if needed. Not more than 8 doses to be taken in 24 hours.

Side effects

Black stool and black tongue is common with use of Bismuth Subsalicylate. Bismuth Subsalicylate should not be used if symptoms are severe or persist for more than 2 days. Do not exceed the recommended dose, shake the bottle before use. For oral use only.

Precautions and warnings

Do not take with aspirin or other salicylates. Caution should be exercised by patients taking medicines for anti-coagulation (thinning of the blood), diabetes or gout.

Pregnancy and lactation

There are no adequate data concerning the use of Bismuth Subsalicylate in pregnant women. Animal studies are insufficient with respect to effects on pregnancy, embryonal/foetal development, parturition and postnatal development. The potential risk for humans is unknown. Bismuth Subsalicylate should not be used during lactation unless clearly necessary.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250